Intech Biopharm Corporation (TPEX:6461)
Taiwan · Delayed Price · Currency is TWD 16.10
-0.35 (-2.13%)
At close: Jul 9, 2026
Intech Biopharm Market Cap
Intech Biopharm has a market cap or net worth of 2.87 billion as of July 9, 2026. Its market cap has increased by 2.54% in one year.
Market Cap
2.87B
Enterprise Value
3.95B
Revenue
117.49M
Ranking
n/a
PE Ratio
n/a
Stock Price
16.10
Market Cap Chart
Since July 15, 2014, Intech Biopharm's market cap has decreased from 4.00B to 2.87B, a decrease of -28.30%. That is a compound annual growth rate of -2.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 2.87B | -0.98% |
| Dec 31, 2025 | 2.90B | -20.37% |
| Dec 31, 2024 | 3.64B | -11.36% |
| Dec 29, 2023 | 4.11B | 5.65% |
| Dec 30, 2022 | 3.89B | 67.22% |
| Dec 30, 2021 | 2.33B | 11.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SYN-TECH Chem. & Pharm. | 3.33B |
| BioGend Therapeutics | 3.27B |
| Energenesis Biomedical CO.,LTD. | 3.23B |
| Shine-On BioMedical | 3.18B |
| Chunghwa Chemical Synthesis & Biotech | 3.04B |
| Apex Biotechnology | 2.99B |
| BRIM Biotechnology | 2.92B |
| GlycoNex Incorporation | 2.90B |